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ABSTRACT
Chagas disease (CD) — a tropical parasitic disease caused by the protozoan Trypanosoma cruzi — is a major health problem 
in Latin America. The immune response against the parasite is responsible for chronic CD lesions. Currently, there are 
no reports of an association between CD and membranous nephropathy (MN). The detection of the phospholipase A2 
receptor (PLA2R) as a target antigen in idiopathic MN can improve the differential diagnosis of primary and secondary 
forms of MN. The authors report the case of a male patient with positive serology for CD who presented sudden death 
and underwent autopsy. Histological sections of the heart showed multifocal inflammatory infiltrate composed mainly 
of mononuclear cells, leading to myocardiocytes necrosis and interstitial fibrosis. The kidneys showed a MN with positive 
expression for PLA2R. As far as we know, this is the first report of a case of primary MN in a patient with CD, with severe 
chronic cardiomyopathy and heart failure. 
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INTRODUCTION
Chagas  d i sease  (CD)  i s  a  ma jo r  hea l th 
problem in Latin America.1 There are an estimated 
15-17 million people infected by Trypanosoma cruzi 
and 90-100 million are exposed to it. The infection is 
mainly transmitted through insect bites by inoculation 
of the feces of infected triatomine through the 
punctured skin.1
Morbidity is related to the intensity of parasitism, 
the biological characteristics of the infecting strains 
and clones, the number of re-infections, and the host 
response. It is characterized by an acute phase with 
intense parasitism with or without symptoms, followed 
by a chronic phase, which usually presents as an 
asymptomatic undetermined form that may evolve to 
cardiac and/or digestive forms.1
About one-quarter of infected individuals develop 
chronic chagasic cardiomyopathy, which is the 
most severe form of the disease. The pathogenesis 
is unknown and some authors suggest an immune 
response to persistent parasites or parasite antigens.2-4 
The lack of correlation of rare tissue parasitism in the 
chronic phase and the intensity of the inflammatory 
process supports the hypothesis of a break of 
immunological tolerance to heart antigens by T. cruzi 
infection with an autoimmune response.4
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Several endemic infectious diseases are associated 
with glomerulopathies in Brazil. The most frequent are 
proliferative forms of glomerulonephritis associated 
with hepatoesplenic schistosomiasis in northeast 
Brazil.5 There are no reports of glomerulonephritis 
associated with CD in humans. Costa et a l . 3 
demonstrated that mice infected with T. cruzi can 
develop a mesangial glomerulopathy mediated by 
immune complexes containing parasite antigens 
and the rheumatoid factor during the chronic phase 
of the disease. There is no known association of 
membranous nephropathy (MN) with CD described 
in the literature. Primary MN, a common cause 
of the nephrotic syndrome in adults, is an organ-
specific autoimmune disease with involvement of 
the M-type phospholipase A2 receptor (PLA2R) as a 
major target antigen.6 The assessment of both the 
circulating PLA2R autoantibody and PLA2R in the 
biopsy samples has been valuable for the differential 
diagnosis between primary and secondary forms of 
MN with prognostic and therapeutic implications.7-10
The aim of this report is to discuss a case of 
idiopathic MN, with enhanced glomerular expression 
of PLA2R, in a patient with a severe form of chagasic 
cardiomyopathy.
CASE REPORT
A 58-year-old male bricklayer who was born in 
northeast Brazil had a diagnosis of CD presenting 
a positive reaction for anti-T. cruz i antibodies. 
An electrocardiogram showed right bundle branch 
and left anterior fascicular blocks, which are common 
electrocardiographic abnormalit ies of Chagas 
cardiomyopathy (Figure 1).1
Anti-HCV, anti-HBs, AgHBs, anti HIV 1 and 2, and 
anti-HTLV I/II were negative. Anti-HBC was positive. The 
patient had been treated for tuberculosis 19 years ago 
and was a tobacco smoker. Clinical follow-up was lost 
soon after he started the treatment for congestive heart 
failure. He died suddenly and the autopsy was performed.
AUTOPSY FINDINGS
The ectoscopy revealed a mulatto, slightly 
overweight, tall man. His heart weighed 500 g 
(reference value [RV]: 350 g) and showed myocardial 
hypertrophy and dilation of all cardiac chambers 
without other typical findings of CD. On histological 
examination, there was interstitial and perivascular 
inflammatory infiltration by mononuclear cells with 
many plasma cells, foci of myocardial cell necrosis, 
and interstitial fibrosis (Figure 2). There was chronic 
passive congestion of the lungs, liver, and spleen 
(weights: lungs 1.760 g [RV: 800-1000 g]; liver 
1.865 g [RV: 1400-1600 g]; spleen 335 g [RV: 150 g]). 
Megaesophagus and megacolon were not found.
The k idneys  gross  f ind ings  revea led no 
abnormalities. The histological examination showed 
an MN characterized by uniform and diffuse thickening 
of the glomerular capillary walls, discrete tubular 
Figure 1. Electrocardiogram showing sinus bradycardia 
(with normal PR interval), right bundle branch, and left 
anterior fascicular blocks.
Figure 2. Photomicrography of the heart showing 
interstitial and perivascular lymphomononuclear 
inflammatory infiltrate with many plasma cells 
(H&E, 400X).
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atrophy, and interstitial fibrosis (Figure 3). There were 
no suspected signs or symptoms of glomerular disease 
in the patient’s clinical record; it was an incidental 
autopsy finding.
Electron microscopy analysis, performed on 
fixed paraffin-embedded tissue obtained from the 
autopsy, showed intense thickening of the glomerular 
basement membrane due to electron-dense deposits 
intermingled with lucent areas of dissolution of these 
deposits (Figure 4).
Immunofluorescence for PLA2R, performed on 
formalin-fixed paraffin-embedded renal tissue by 
Hanna Debiec (Institut National de la Santé et de la 
Recherche Médicale),10,11 was positive (Figure 5).
Figure 5. Glomerular expression of the M-type 
phospholipase A2 receptor (PLA2R- 400X).
Figure 3. Photomicrography of the kidney. 
A - (HE, 400X); B - (PAS, 400X) – Membranous 
nephropathy (MN) characterized by uniform and diffuse 
thickening of the glomerular capillary walls; C - Irregular 
basement membrane with spiked and holey appearance 
(Churg stage II-III) (Methenamine silver stain 400X).
Figure 4. Thickened glomerular basement membrane 
(GBM) by incorporated heterogeneous deposits (stage 
III to IV MGN). Some of the deposits are electron-dense 
(D) and the lucent areas are consistent with resorbed 
deposits (L); segmental foot process effacement (P) 
(EM bar scale 500nm).
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Fibrosis with a distortion of pulmonary architecture 
and fibrous pleuritis in the apical area of the right lung 
was present, which could be a consequence of the 
previously treated tuberculosis. Severe centrilobular 
emphysema was also found. In addition, there was 
mild systemic atherosclerosis and benign prostatic 
hyperplasia.
DISCUSSION
Worldwide, MN is a common cause of nephrotic 
syndrome in adults. In approximately two-thirds of 
cases, the etiology is unknown and is referred to as 
primary. Some examples of the causes of secondary 
cases are chronic viral, bacterial, and parasitic infections; 
neoplasia; drugs; and other autoimmune diseases. 
Experimental studies have shown that in the primary 
form there is a reaction between a circulating antibody 
and an intrinsic antigen in the subepithelial side of the 
glomerular basement membrane with the formation 
of in situ immune complexes. Complement activation 
with the generation of membrane attack complex 
C5b-9 can explain the podocyte injury, morphological 
changes, and proteinuria.11 Recent evidence has shown 
that up to 70% of patients with primary MN have 
non-complement-fixing IgG4 autoantibodies to PLA2R, 
a target antigen located at the podocytes. MN, like 
most immune glomerular diseases, is a manifestation 
of an immune response to self-antigens expressed on 
the podocyte cell membrane.7-9,12
The case presented herein showed the association 
of an active chronic chagasic myocarditis with a primary 
MN positive for PLA2R in the glomeruli. In this patient, 
it seems that PLA2R expression confirmed primary MN, 
and the association with CD is just coincidental.
The presence  of  c i r cu la t ing ant i -PLA2R 
autoantibodies shows the specificity of 57–89% for the 
diagnosis of primary MN.7,8,13-15 However, some of these 
studies tested PLA2R only in groups of patients with 
primary MN, excluding the cases with secondary MN.15-17 
Studies that tested PLA2R in cases with secondary MN 
sampled a small number of patients, most of whom 
had autoimmune diseases and neoplasia, but not 
infectious diseases.18-21 Qin et al.13 measured serum 
anti-PLA2R autoantibodies in 60 primary MN patients 
and 46 secondary MN patients, 16 of whom had 
hepatitis B virus (HBV)-associated MN. Anti-PLA2R 
antibodies were detected in only three patients with 
HBV. The patients did not have clinical remission with 
antiviral treatment, and the authors inferred that these 
patients had a coexistence of two diseases.
Taking all of these considerations into account, 
the detection of PLA2R circulating antibodies still does 
not rule out a secondary cause, the investigation of 
which is expensive and time-consuming in the routine 
practice of MN.
Old studies have shown that high levels of 
proteinuria, initial increased serum creatinine 
determination, and interstitial fibrosis were significant 
predictors of a poor outcome of MN.22-24 However, 
these markers are not adequate to guide and evaluate 
treatment efficacy. Spontaneous remission can occur 
in patients with heavy proteinuria.25 The positive 
correlation between the presence of circulating 
anti-PLA2R and immunological activity makes the 
PLA2R test useful to evaluate the activity of the disease, 
and is a source of information for treatment. High 
levels of anti-PLA2R are present in association with 
severe proteinuria, which decreases during remission 
and increases with a relapse of the disease. It has been 
suggested that the serum levels of anti-PLA2R can be 
used for the diagnosis and monitoring of the treatment 
of primary MN.12,14,15
In this case, there was no blood sample to 
evaluate the activity of the disease; MN was discovered 
incidentally during autopsy. The kidneys showed 
morphologically glomerular basement membrane 
thickening stage II to III, with minimal tubular atrophy 
and interstitial fibrosis, and a strong positivity for 
PLA2R in the glomeruli. Notwithstanding, a positive 
correlation between PLA2R glomerular deposits 
and anti-PLA2R serum levels is not the rule. Debiec 
and Ronco8 studied 42 patients with MN and found 
10 with PLA2R glomerular deposits but anti-PLA2R 
serum negativity. The serum clearing of anti-PLA2R 
antibodies can occur because of renal tissue deposition. 
Svobodova et al.26 in a retrospective cohort of 
65 patients with primary MN, found 6 patients negative 
for circulating anti-PLA2R antibodies but with positive 
kidney biopsies for PLA2R antigen during active disease. 
At the time of remission 37 patients were biopsied 
again and 15 of them were negative for anti-PLA2R 
circulating antibodies, but the antigen was found in 
the corresponding biopsies. In summary, detection of 
PLA2R in biopsies is an important diagnostic tool in the 
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absence of serum samples. It can make a differential 
diagnosis with secondary MN—mainly lupus MN—but 
is useless in providing any information on the activity 
of the disease. The case presented herein could have 
been in an initial phase of active disease, or even in 
partial or complete remission.
Most authors agree that patients who have 
elevated initial serum creatinine evolve more frequently 
to end-stage renal failure.22,24,27 In order to assess the 
relationship between anti-PLA2R and clinical outcome, 
Oh et al.19 tested autoantibodies in serum samples at 
the time of biopsy in 100 patients with primary MN, 
but neither the presence of, nor the levels of, the anti-
PLA2R antibody showed a significant correlation with 
the clinical outcome.
In conclusion, this case report shows a patient 
who presented, concomitantly, two unrelated diseases: 
primary MN PLA2R positive and Chagas myocarditis.
The detect ion of  c i rcu lat ing ant i -PLA2R 
autoantibodies is very useful in monitoring the activity 
of the disease and the treatment efficacy. Further 
studies with a larger sample of secondary forms of MN 
are needed to better understand the prevalence of the 
PLA2R test in the serum and in the kidney biopsies of 
primary MN.
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